Signature substrate mutations associated with HIV-1 protease inhibitor resistance

被引：0
|
作者：
Kolli, M. [1 ]
Stawiski, E. [2 ]
Chappey, C. [2 ]
Parkin, N. [2 ]
Schiffer, C. A. [1 ]
机构：
[1] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA
[2] Monogram Biosci Inc, San Francisco, CA USA
来源：
ANTIVIRAL THERAPY | 2007年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [1] Signature substrate mutations associated with HIV-1 protease inhibitor resistance
    Kolli, M.
    Stawiski, E.
    Chappey, C.
    Parkin, N.
    Schiffer, C. A.
    ANTIVIRAL THERAPY, 2007, 12 (05) : S144 - S144
  • [2] HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance
    Rhee, Soo-Yon
    Taylor, Jonathan
    Fessel, W. Jeffrey
    Kaufman, David
    Towner, William
    Troia, Paolo
    Ruane, Peter
    Hellinger, James
    Shirvani, Vivian
    Zolopa, Andrew
    Shafer, Robert W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (10) : 4253 - 4261
  • [3] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Axel Fun
    Noortje M van Maarseveen
    Jana Pokorná
    Renée EM Maas
    Pauline J Schipper
    Jan Konvalinka
    Monique Nijhuis
    Retrovirology, 8
  • [4] HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
    Fun, Axel
    van Maarseveen, Noortje M.
    Pokorna, Jana
    Maas, Renee E. M.
    Schipper, Pauline J.
    Konvalinka, Jan
    Nijhuis, Monique
    RETROVIROLOGY, 2011, 8
  • [5] A Surveillance on Protease Inhibitor Resistance-Associated Mutations Among Iranian HIV-1 Patients
    Nasiri-Tajabadi, Zeynab
    Salim, Farah Bokharaei
    Najafzadeh, Mohammad-Javad
    Kalantari, Saeed
    Garshasbi, Saba
    Jamehdar, Saeid Amel
    Farsiani, Hadi
    Mazaheri, Zahra
    Sankian, Mojtaba
    Youssefi, Masoud
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2018, 13 (06):
  • [6] HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1
    Pieniazek, D
    Rayfield, M
    Hu, DJ
    Nkengasong, JN
    Soriano, V
    Heneine, W
    Zeh, C
    Agwale, SM
    Wambebe, C
    Odama, L
    Wiktor, SZ
    Kalish, ML
    AIDS, 2004, 18 (03) : 495 - 502
  • [7] In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix
    Datir, Rawlings
    Kemp, Steven
    El Bouzidi, Kate
    Mlchocova, Petra
    Goldstein, Richard
    Breuer, Judy
    Towers, Greg J.
    Jolly, Clare
    Quinones-Mateu, Miguel E.
    Dakum, Patrick S.
    Ndembi, Nicaise
    Gupta, Ravindra K.
    MBIO, 2020, 11 (06): : 1 - 15
  • [8] HIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance
    Laco, Gary S.
    BIOCHIMIE, 2015, 118 : 90 - 103
  • [9] Mutations in HIV-1 reverse transcriptase and protease associated with drug resistance
    Mellors, JW
    Larder, BA
    Schinazi, R
    Deverson, C
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 92 - 92
  • [10] Influence of Major HIV-1 Protease Inhibitor Resistance Mutations on CTL Recognition
    Mueller, Sandra M.
    Spriewald, Bernd M.
    Bergmann, Silke
    Eismann, Kathrin
    Leykauf, Melanie
    Korn, Klaus
    Walter, Hauke
    Schmidt, Barbara
    Arnold, Marie-Luise
    Harrer, Ellen G.
    Kaiser, Rolf
    Schweitzer, Finja
    Braun, Patrick
    Reuter, Stefan
    Jaeger, Hans
    Wolf, Eva
    Brockmeyer, Norbert H.
    Jansen, Klaus
    Michalik, Claudia
    Harrer, Thomas
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2011, 56 (02) : 109 - 117
12345